Hemorai

AI-Powered Blood Analysis

health AI / medtech / digital health

Visit website

Stageseed

Founded2019

Employees3

LocationAustin, TX

About

Giving birth is one of the most dangerous things a woman can do. Out of every 100,000 live births, 216 results in maternal morbidity, but this statistic fails to convey how dangerous birth can be for mothers in developing countries. While worldwide maternal mortality rates are slowly declining, the risk of maternal mortality skyrockets in rural or developing areas, where child-birth complications pose a more substantial and widespread problem. Resource-poor countries and communities comprise a disproportionate 99% of maternal mortalities, and the rate of maternal mortality has continued to rise rather than fall. The most common cause of maternal mortality is postpartum hemorrhage (PPH). In rural and resource-poor countries, the chances of dying due to postpartum hemorrhage are nearly 100 times higher than in developed countries. Even in developed countries, 18% of pregnant women experience dangerous levels of blood loss, making PPH the biggest contributor to maternal mortality worldwide. Hemorai has developed a portable and affordable device, that is capable of providing accurate blood loss levels and alerting physicians of the actual hemoglobin and hematocrit levels, hence applying correct treatment to prevent hemorrhagic shock and unnecessary blood transfusions.

Product

Value proposition: Advanced wearable technology that continuously monitors blood loss and vital signs, providing real-time data to caregivers and patients for better health outcomes.

Founders

Thomas Milner, Ph.D. — Co-founder & Chief Scientific Officer
Hector Torres, M.Sc. — Co-founder & CEO
Dr. Sina Haeri, MD — Co-founder & Chief Medical Officer

Products

Portable Monitoring devicesReal-time alert systemPatient-centered interface

Key features

Portable monitoringReal-time alertsPatient-centered interface

Technologies

AI-powered analysiswearable sensorsreal-time data analytics

Partnerships

Impact partnerships with institutions (e.g., universities and medical centers listed in links)Collaborations with WPI, UTMB, Dell Medical School, UCI, UMass Medical, NSF, NIH, Boomtown Accelerator, Mehi Massachusetts, UML M2D2, Call Copic (as partners or collaborators)

Investors

Right Side Capital Management

News

Hemorai 2026 Company Profile: Valuation, Funding & Investors · 2025-11-01T00:00:00.000Z
[PDF] Smart Wearable for Real - Time Blood Loss Detection · 2026-03-05T00:00:00.000Z
Inside the 7th Annual CAPCaT Point-of-Care Showcase - LinkedIn · 2026-06-10T00:00:00.000Z
[PDF] IMPACT REPORT - UMass Chan Medical School · 2025-07-15T00:00:00.000Z
Electrodes for Medical Devices Market Worth $5.8 Billion by 2032 · 2026-06-25T00:00:00.000Z
Scaling Cataract Surgery: Human Resource Efficiency and Quality ... · 2026-06-01T00:00:00.000Z

Browse similar startups

Related startups

InfuseFlow — Dallas, TX
Insara — Houston, TX
InSight Psychology and Behavioral Health Services LLC — Pflugerville, TX
Insiteflow — Austin, TX
Intelligenome — Houston, TX
iSpin Health — Frisco, TX
HERITAGE MILLS PERSONAL CARE CENTER — tower city, PA
Hindsait, Inc. — Hackensack, NJ
Hippos — San Francisco, CA
HOLYOKE PEDIATRIC ASSOCIATES, LLP — Holyoke, MA
Hope Behavioral Health — Minneapolis, MN
HOPE SPRINGS BEHAVIORAL HEALTH INC — Jamison, PA

Profile updated Jul 29, 2026. Sources: hemorai.com, wpi.edu